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Evaluation the predictive value of perioperative Plasma B-type natriuretic
peptide level in arterial switch operation. Plasma B-type natriuretic peptide level was
measured before and  and 24 hours after surgery in 29 patients with arterial switch
operation. We evaluated 29 patients (22 male,76%,7 female 24%) with mean age 67.93±84.09
days (range 6 days to 14months).The mean of BNP level before surgery was 7989.96±9691.94
and increased after surgery to 22391.35±11898.67 and difference between two groups was
significant (P=0.003).In linear regression test the BNP did not correlate with sex(r=0.33,
P=0.085) and age(r=0.14,P=0.45). Furthermore, BNP did not correlate with duration of
mechanical ventilation (r=0.132,P=0.53) , ICU stay (r=0.137,P=0.52) and with lactate
level (r=0.41,P=0.054)after operation. During the study 4 patients(13.8%) died and the
mean of BNP 24h after operation among them was 35000.00±00.00.using chai-square and
fisher exact test the correlation between BNP  and death was significant(P=0.001). We
implied that BNP  level increased 24 hours after arterial switch operation, moreover we
denoted it correlated well with the death rate and an increase in B-type natriuretic
peptide 24 hours after surgery predicts poor postoperative outcome. However it did not
correlate with duration of mechanical ventilation ,ICU stay and lactate level in this
patients.
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B-type natriuretic peptide (BNP) is a
cardiac neurohormone secreted from membrane
granules in the cardiac ventricles as a response to
ventricular volume expansion and pressure
overload. BNP is a 32-amino acid polypeptide
hormone, with diuretic, natriuretic, and vasoactive
actions, and use as a biomarker for the management
of cardiac disease in both pediatric and adults’
patients1-4.
Recently a study in patients with
congenital heart defects amenable to biventricular
repair indicated that measurement of circulating
levels of BNP can predict the development of  low
cardiac output syndrome (LCOS) and prolonged
mechanical ventilation (5).Furthermore, other
studies indicated higher plasma level of BNP in
children with congenital heart disease and
newborns with severe fetal distress (6-8).Because
of serious complications related to congenital
cardiac defects, surgical repair or palliation of
congenital cardiac defects is carried out usually
during the neonatal period (8-9).Moreover,
neonates,compared to  infants and children, have
more adverse events and  perioperative mortality.
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On the other hand,the clinical predictive value of
perioperative plasma BNP levels in neonates, who
are most at risk for unpredictable adverse
outcomes, is controversial5-10. So, we steered this
study to address these concerns and to shed light
on predictive value of preoperativeBNP plasma
level in patients under cardiac surgery .
MATERIALS AND METHODS
We directed a prospective cohort study
in the Rajaiee cardiac hospital at the Tehran
University of medical sciences between May 2012
and September 2012. The study protocol was
approved by ethical committee of Tehran
University of medical sciences. Furthermore, we
obtained written informed consent from the
patients’ parents or guardians before enrollment
in the study.
Eligible patients were children  withTGA
undergoing arterial switch operation.The
preoperative anesthesia management,
intraoperative bypass strategy, and subsequent
Pediatric Cardiac Intensive Care Unit management
followed standard institutional practices. All
patients underwent modified ultrafiltration before
separating from CPB. An on-service team, blinded
to the BNP values, made all patient management
decisions.
Data Collection
Blood samples were obtained from an
arterial catheter 2 hours before operation and 24
hours after CPB.The samples were placed
immediately on ice in chilled
ethylenediaminetetraaceticacid tubes and
centrifuged at 3000 rpm for 15 minutes at 4°C.
Separated plasma was stored at _20°C.
Within 4 days of obtaining the sample, the plasma
was thawed to room temperature and BNP levels
were measured using a commercially available
fluorescence immunoassay (Triage Meter Plus,
BiositeDiagnostic, San Diego,Calif). The
measurable range of BNP on this device is between
5 and 5000 pg/mL. The estimated coefficient of
variation for the assay is 9.2% to 11.4%.
Clinical and biochemical data were
collected prospectively at each sampling point and
daily thereafter by an observer blinded to the BNP
data. The clinical data collected included the
patient demographics, CPB duration, aortic cross
clamp duration, inotrope dose, intensive care unit
days, hospital days, and use of
mechanical ventilation. Biochemical data
collected included Hb , BS, serum lactate, blood
urea nitrogen, and creatinine level.
Statistical analyses
Data were analyzed using SPSS version
20.Categorical data are presented as numbers (%),
and continuous data as mean ± SD. We used the
Chai_2 or Fisher’s exact test to compare categorical
variables and the Student’s t test, the paired ttest,
or the Mann-Whitney’s rank sum U test to compare
continuous variables. Correlations between BNP
concentrations and hemodynamic variables were
calculated by Spearman rank correlation analysis.
RESULTS
In this study we evaluated 29 children
(22 boy,76%,7 girls 24%) with mean age 67.93±84.09
days (range 6 days to 14months). The patients
main cardiac lesions wereVSD,ASD,dTGA PDA.All
patients after operation needed inotropic agents
as epinephreine,milrinone,dobutamine, adrenaline
and dopamine.
The mean of BNP before surgery was
7989.96±9691.94 and increased after surgery to
22391.35±11898.67 and difference between two
groups was significant (P=0.003)(Table1).In linear
regression test the BNP did not correlate with
sex(r=0.33,P=0.085) and age(r=0.14,P=0.45)
.Furthermore,BNP did not correlate with ventilation
Table 1 . BNP, BUN and Cr pre and post operation
pre post Pvalue
BNP 7989.96±9691.94 22391.35±11898.67 0.003
BUN 9.47±3.43 10.35±3.77 0.30
Cr 0.57±16 0.60±0.32 0.35
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time (r=0.132,P=0.53), ICU stay (r=0.137,P=0.52) and
with lactate level (r=0.41,P=0.054)after operation.
During the study 4 patients(13.8%) died and the
mean of BNP 24 after operation among them was
35000.00±00.00.using chai-square and fisher exact
test the correlation between BNP  and death was
significant(P=0.001).
various congenital heart diseases such as atrial
septal defect,ventricular septal defect, and
tetralogy of fallot and with cyanotic heart
diseases21.
Furthermore in another survey, Suda et
al.signified that plasma BNP level reflects pressure
and volume loading of the right ventricle and the
pulmonary artery,so, they purposed that BNP
determinations may help to identify children with
ventricular septal defect complicated by pulmonary
hypertension, which needs urgent intervention22.
These findings recommend that BNP may be a
valuable biomarker for prognostication and risk
stratification in neonates undergoing cardiac
surgery and the measurement of plasma BNP may
add clinically useful information relevant to the
management of children with congenital heart
disease.
In this clinical trial we indicated that the
mean of BNP 24 hours after operation significantly
increased (7989.96±9691.94 vs.22391.35±11898.67,
P=0.003), moreover in four patients that died after
operation the mean of BNP plasma level was higher
than other(35000 vs. 22391)and the correlation
between death and BNP was significant(p=0.001).In
agreement to our results Koch et al. in a study
signified that in children with congenital heart
defects plasma BNP level increased immediately
after cardiac surgery23.Moreover another study by
Shih etal.showed B-type natriuretic peptide levels
increased after separation from cardiopulmonary
bypass, with an 8-fold peak increase at 12
hours24.However, in contrast to our results HSU et
al evaluated the plasma B-type natriuretic peptide
levels in 36 consecutive neonates and indicated
that B-type natriuretic peptide levels at 24 hours
were lower than preoperative levels12.Moreover
Sanjeevet al.in another survey specified that
elevation of plasma BNP accurately detects the
presence of  PDA in premature infants. Also,
theydesignated that successful closure is reflected
by a corresponding decrease in BNP plasma level
in neonates25.A possible explanation for such a
discrepancy between studies is heterogeneity in
patient’s samples and different technique in BNP
measurement.
Our results did not show any correlation
between BNP and serum lactate and duration of
mechanical ventilation after surgery and BNP but
conversely,Sanjeev etal. in their review pointed out
Table 2. The mean and SD of variables
variables Mean SD
Hb 14.14 2.84
BS 76.10 15.36
Pomp duration 164.00 44.90
Clamp 102.41 32.95
Transfusion during operation 182.69 116.80
Lactate* 5.29 2.75
Lactate* 3.90 2.54
Lactate* 3.30 2.04
Lactate* 2.93 1.72
Lactate** 2.77 1.58
Lactate** 1.88 1.78
Ventilation post operation(hour) 82.46 72.59
ICU stay(day) 7.41 3.56
Bleeding post operation 53.27 91.42
Transfusion post operation 70.17 74.05
*lactate one day after operation every 6 hours
**lactate two days after operation every 12 hour
DISCUSSION
There are little evidencesto suggest that
BNP may be helpful in a pediatric clinical setting11.
However, it is clear that it increases in various
pathologic states; particularly those involved in
increased cardiac chamber wall stretch and
expanded fluid volume as heart failure, renal failure,
primary hyperaldosteronism, and in reduced
peptide clearance as in renal failure11, 12.
Furthermore some studies indicated that BNP
seems to have clinical utility in terms of excluding
the diagnosis of heart failure in patients with
symptoms of breathlessness or fluid retention and
may provide prognostic information about those
with heart failure or other cardiac diseases13-18 Also,
there is some evidence that it may be useful for
monitoring heart failure therapies19-20.
Ootaki et al in a study indicated that
plasma BNP levels correlate well with biventricular
volume, particularly with left ventricular volume in
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that cardiopulmonary bypass time and serum
lactate concentration correlated to BNP25.
Moreover, Shih et al showed postoperative 12-hour
B-type natriuretic peptide levels were related with
the duration of mechanical ventilation and low
cardiac output after surgical treatment24.
During the study 4 patients died and the
mean of BNP 24hours after operation among them
was more than 35000 that is higher than other
patients, more over death rate significantly correlate
with BNP plasma level. In line with our outcomes
Price et al. in a study pointed out that BNP
concentrations increase in children with chronic
LV systolic dysfunction and predict the 90-day
composite end point of death, hospitalization, or
listing for cardiac transplantation26.
The main limitations are inherent to the
present study are the relatively small sample size
and short duration of follow-up. Further
investigations are recommended with longer follow-
up and larger series to validate the findings
reported  here.
CONCLUSION
we implied that BNP plasma level
increased 24 hours after surgical intervention in
children with congenital heart disease, moreover
we denoted it correlated well with the death rate
and an increase in B-type natriuretic peptide 24
hours after surgery predicts poor postoperative
outcome. However it did not correlate with
ventilation time and lactate level in this patients.
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